The stock surged ₹5.71 to touch an intraday high of ₹2,775 per share on the NSE, merely ₹10 shy of its 52-week high of ₹2,785, scaled last month on October 8
With a balanced east-west coast presence and expanding inland logistics capabilities, JSWINFRA, analysts believe, is well-placed to benefit from India's push for multimodal integration
Tushar Manudhane, Vipul Mehta, and Eshita Jain, research analysts at MOFSL, value Aurobindo Pharma at 16 times 12-month forward earnings, assigning a target price of ₹1,430
Parvez Qazi and Vasudev Ganatra, research analysts at Nuvama, expect Embassy REIT to clock a DPU compound annual growth rate (CAGR) of 13 per cent over FY25-28E on the back of strong office demand
Stocks to Watch Today, December 4, 2025: Infosys, Pine Labs, ONGC, Bank of Maharashtra, Tata Capital, Lemon Tree Hotels, Vintage Coffee are among the top stocks to watch today
The brokerage said most major OEMs reported double-digit year-on-year volume growth, aided by festive spillover, GST 2.0-led affordability, improved rural sentiment and robust export demand
Stocks to Watch today, December 03: Shares of SBI, HDFC Bank, and ICICI Bank will remain in focus today as RBI has announced that they will continue to be classified as systemically important banks
The brokerage has retained its Buy rating on Adani Ports shares, with a revised target price of ₹1,770, implying a 16 per cent upside from the current market price of ₹1,531 per share
Terming the transaction value-accretive, Nuvama analysts Parvez Qazi and Vasudev Ganatra have reiterated their 'Buy' rating on the REIT, with a DCF-based target price of ₹507
Stocks to Watch Today, December 2, 2025: Hindalco Industries, Hindustan Unilever, NMDC, Vedant Fashions, AU Small Finance Bank, and Fineotex Chemical are among the top stocks to watch today
Around 10:30 AM, Sterling & Wilson Renewable Energy shares continued to trade higher, up 1.97 per cent at ₹230.40 apiece. In comparison, BSE Sensex was trading 0.30 per cent higher at 85,964.58 levels
Analysts at JM Financial have reiterated their bullish stance on the stock, maintaining a Buy rating with a target price of ₹370 per share, based on a 23x FY27E price-to-earnings (P/E) multiple
The brokerage said Lenskart's vertically integrated omnichannel model; spanning design, manufacturing and retail; drives cost efficiency, faster delivery and a superior customer experience.
Eternal, with its category leadership and Blinkit's rapid horizontal expansion, is well-positioned to replicate this trend in India, providing high visibility for sustained growth
SeQuent Scientific and Viyash Lifesciences Private Limited announced through an exchange filing that the NCLT has approved the merger scheme between SeQuent and the Viyash group of companies.
Analysts see nearly 17 per cent upside at current levels and have valued Medanta at a 30x12M EV/Ebitda multiple, arriving at a target price of ₹1,480 per share
